Sign In
test

Neb Obradovic

Cormorant Asset Management, Lp

Assets Managed
$1.991B
Holdings
46
Last Quarter
2026 - Q1
Filed Date
1mo 9d ago
Growth Rate
-7.93%(2Q avg: 20.65%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Cormorant Asset Management, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 46 positions.

Assets under management

The assets under management (AUM) of Cormorant Asset Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.991B in assets, with a quarterly growth rate of -7.93% and a 2-quarter average growth rate of 20.65%. The portfolio is managed by Neb Obradovic, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PRAX
Praxis Precision Medicines I
Recent Activity
Decreased -6.78%
14.33%
$285.299M
885,500 shares@ $322.19 avg price
BBOT
Bridgebio Oncology Therapeut
Recent Activity
8.04%
$160.013M
17.879M shares@ $8.95 avg price
EYPT
Eyepoint Pharmaceuticals Inc
Recent Activity
5.36%
$106.536M
8.265M shares@ $12.89 avg price
EWTX
Edgewise Therapeutics Inc
Recent Activity
Decreased -0.76%
5.16%
$102.69M
3.26M shares@ $31.5 avg price
ERAS
Erasca Inc
Recent Activity
New Position
4.72%
$93.844M
5.8M shares@ $16.18 avg price
RAPP
Rapport Therapeutics Inc
Recent Activity
Decreased -2.31%
4.65%
$92.541M
2.958M shares@ $31.29 avg price
ALMS
Alumis Inc
Recent Activity
Increased 8.63%
4.37%
$87.002M
3.949M shares@ $22.03 avg price
ABVX
Abivax Sa-adr
Recent Activity
Decreased -43.7%
4.26%
$84.626M
760,000 shares@ $111.35 avg price
MLTX
Moonlake Immunotherapeutics
Recent Activity
Increased 2.87%
4.2%
$83.515M
4.48M shares@ $18.64 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
New Position
4.01%
$79.724M
950,000 shares@ $83.92 avg price

1-10 of 46